Apollo Hospital to Build 573 Cr Gurugram Oncology Center Featuring Next-Gen Proton Therapy System

The Gurugram center will comprise a 100-bed comprehensive facility providing an integrated cancer care for the patients

Apollo Hospitals Enterprise Ltd has announced plans to set up a state-of-the-art oncology center in Gurugram, with a total investment of ₹573 crore. The facility is expected to be equipped with next-generation proton therapy technology, making it one of the most advanced cancer treatment centers in North India.

The Gurugram Facility is Apollo’s third proton therapy initiative in India, following its flagship center in Chennai, which was the first in South Asia and the Middle East, and has treated over 2,500 patients from 147 countries. The second facility is currently under development at Jubilee Hills, Hyderabad, within a 70-bed cancer center.

The Gurugram center will comprise a 100-bed comprehensive facility providing an integrated cancer care for the patients.

Further, the center will include Advanced Multi-System Robotics enabling minimally invasive cancer surgeries; High-End Linear Accelerators for image-guided and adaptive radiotherapy; and Immunotherapy and Targeted Therapies to deliver personalized treatment plans.

Additionally, the center will feature Genomics-Driven and Personalized Medicine, aligning therapies with each patient’s unique biology; Bone Marrow Transplants and CAR T-Cell Therapies for blood disorders and complex cancers.

As per reports, the new center will be part of the Phase 2 expansion of Apollo’s upcoming 500-bed hospital in the city, with completion expected by FY29.

Moreover, the facility is anticipated to treat an additional 350 patients annually by FY29, significantly enhancing access to advanced cancer care in the National Capital Region.

The Apollo Group aims to expand its oncology growth strategy across five key markets, namely Chennai, Hyderabad, Mumbai, Bengaluru, and the NCR, while planning further investments in other cities.

The group intends to double the scale of its oncology business to over ₹5,000 crore within the next three to four years

Commenting on the initiative, Dr Prathap C Reddy, Founder-Chairman, Apollo Hospitals Enterprise, said, “At Apollo, we are driven by an unyielding passion for excellence in healthcare. Our commitment is to ensure that India remains at the forefront of medical innovation, providing patients with access to the world’s most advanced treatments. The addition of next-generation proton therapy to our Apollo Proton Cancer Centers further solidifies our position as a global leader in Proton Therapy. This next-generation technology will allow us to achieve superior clinical outcomes and significantly improve the quality of life for cancer patients in India and beyond.”

Stay tuned for more such updates on Digital Health News